SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-281483
Filing Date
2023-11-21
Accepted
2023-11-21 16:05:57
Documents
4
Period of Report
2023-11-21

Document Format Files

Seq Description Document Type Size
1 6-K d579043d6k.htm 6-K 10052
2 EX-99.1 d579043dex991.htm EX-99.1 40393
3 GRAPHIC g579043g1121183546995.jpg GRAPHIC 2869
4 GRAPHIC g579043g1121183547343.jpg GRAPHIC 3596
  Complete submission text file 0001193125-23-281483.txt   60852
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 231428078
SIC: 2834 Pharmaceutical Preparations